The University of Texas at Dallas is a public research university in Richardson, Texas. It is one of the largest public universities in the Dallas area and the northernmost institution of the University of Texas system. It was initially founded in 1961 as a private research arm of Texas Instruments.

During the past decade, University of Texas conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 14 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 11 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Texas" #1 sponsor was "The University of Texas at Dallas" with 21 trials, followed by "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 4 trials sponsored, "National Institute on Aging (NIA)" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Posit Science Corporation" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Texas" #1 collaborator was "The University of Texas at Dallas" with 4 trials as a collaborator, "American Diabetes Association" with 3 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 3 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "University of Texas" are "Healthy Adults" (7 trials), "Alzheimer Disease" (4 trials), "Developmental Language Disorder" (3 trials), "Specific Language Impairment" (3 trials) and "Speech Sound Disorder" (3 trials). Many other conditions were trialed in "University of Texas" in a lesser frequency.

Most popular intervention types in "University of Texas" are "Device" (20 trials), "Drug" (14 trials), "Behavioral" (7 trials), "Other" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "sham tDCS" (5 trials), "Placebo" (4 trials), "tDCS" (4 trials), "Sham tDCS" (3 trials) and "active anodal tDCS" (3 trials). Other intervention names were less common.

The vast majority of trials in "University of Texas" are 40 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Texas". 1 are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in University of Texas, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in University of Texas, 3 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 23 trials that are defined as “Not Applicable".